Logo image of CJR-B.CA

CORUS ENTERTAINMENT INC-B SH (CJR-B.CA) Stock Fundamental Analysis

TSX:CJR-B - Toronto Stock Exchange - CA2208741017 - Common Stock - Currency: CAD

0.1  +0.01 (+5.26%)

Fundamental Rating

2

Overall CJR-B gets a fundamental rating of 2 out of 10. We evaluated CJR-B against 11 industry peers in the Media industry. CJR-B has a bad profitability rating. Also its financial health evaluation is rather negative. CJR-B is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

CJR-B had negative earnings in the past year.
CJR-B had a positive operating cash flow in the past year.
In the past 5 years CJR-B reported 4 times negative net income.
In the past 5 years CJR-B always reported a positive cash flow from operatings.
CJR-B.CA Yearly Net Income VS EBIT VS OCF VS FCFCJR-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

CJR-B has a worse Return On Assets (-47.42%) than 81.82% of its industry peers.
CJR-B's Return On Invested Capital of 6.43% is fine compared to the rest of the industry. CJR-B outperforms 63.64% of its industry peers.
CJR-B had an Average Return On Invested Capital over the past 3 years of 8.40%. This is significantly below the industry average of 32.97%.
Industry RankSector Rank
ROA -47.42%
ROE N/A
ROIC 6.43%
ROA(3y)-24.86%
ROA(5y)-17.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.4%
ROIC(5y)7.93%
CJR-B.CA Yearly ROA, ROE, ROICCJR-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

With a decent Operating Margin value of 9.12%, CJR-B is doing good in the industry, outperforming 72.73% of the companies in the same industry.
In the last couple of years the Operating Margin of CJR-B has declined.
CJR-B has a Gross Margin of 53.83%. This is amongst the best in the industry. CJR-B outperforms 81.82% of its industry peers.
In the last couple of years the Gross Margin of CJR-B has declined.
Industry RankSector Rank
OM 9.12%
PM (TTM) N/A
GM 53.83%
OM growth 3Y-17.74%
OM growth 5Y-11.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.57%
GM growth 5Y-2.57%
CJR-B.CA Yearly Profit, Operating, Gross MarginsCJR-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

More info and screens

1

2. Health

2.1 Basic Checks

CJR-B has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, CJR-B has about the same amount of shares outstanding.
CJR-B has less shares outstanding than it did 5 years ago.
CJR-B has a worse debt/assets ratio than last year.
CJR-B.CA Yearly Shares OutstandingCJR-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CJR-B.CA Yearly Total Debt VS Total AssetsCJR-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

CJR-B has an Altman-Z score of -1.48. This is a bad value and indicates that CJR-B is not financially healthy and even has some risk of bankruptcy.
CJR-B has a worse Altman-Z score (-1.48) than 63.64% of its industry peers.
CJR-B has a debt to FCF ratio of 12.33. This is a negative value and a sign of low solvency as CJR-B would need 12.33 years to pay back of all of its debts.
CJR-B has a Debt to FCF ratio of 12.33. This is in the lower half of the industry: CJR-B underperforms 63.64% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 12.33
Altman-Z -1.48
ROIC/WACC1.55
WACC4.14%
CJR-B.CA Yearly LT Debt VS Equity VS FCFCJR-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 0.65 indicates that CJR-B may have some problems paying its short term obligations.
With a Current ratio value of 0.65, CJR-B is not doing good in the industry: 90.91% of the companies in the same industry are doing better.
A Quick Ratio of 0.65 indicates that CJR-B may have some problems paying its short term obligations.
With a Quick ratio value of 0.65, CJR-B is not doing good in the industry: 90.91% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.65
Quick Ratio 0.65
CJR-B.CA Yearly Current Assets VS Current LiabilitesCJR-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for CJR-B have decreased strongly by -186.36% in the last year.
Measured over the past years, CJR-B shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -43.12% on average per year.
The Revenue for CJR-B has decreased by -14.72% in the past year. This is quite bad
Measured over the past years, CJR-B shows a decrease in Revenue. The Revenue has been decreasing by -5.52% on average per year.
EPS 1Y (TTM)-186.36%
EPS 3Y-61.41%
EPS 5Y-43.12%
EPS Q2Q%-600%
Revenue 1Y (TTM)-14.72%
Revenue growth 3Y-6.28%
Revenue growth 5Y-5.52%
Sales Q2Q%-9.74%

3.2 Future

Based on estimates for the next years, CJR-B will show a very negative growth in Earnings Per Share. The EPS will decrease by -25.99% on average per year.
CJR-B is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.42% yearly.
EPS Next Y-573.8%
EPS Next 2Y-156.92%
EPS Next 3Y-25.99%
EPS Next 5YN/A
Revenue Next Year-11.4%
Revenue Next 2Y-8.68%
Revenue Next 3Y-5.42%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CJR-B.CA Yearly Revenue VS EstimatesCJR-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CJR-B.CA Yearly EPS VS EstimatesCJR-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 1 1.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CJR-B. In the last year negative earnings were reported.
Also next year CJR-B is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CJR-B.CA Price Earnings VS Forward Price EarningsCJR-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CJR-B is valued cheaply inside the industry as 90.91% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CJR-B is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 0.23
EV/EBITDA 1.36
CJR-B.CA Per share dataCJR-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 -6

4.3 Compensation for Growth

A cheap valuation may be justified as CJR-B's earnings are expected to decrease with -25.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-156.92%
EPS Next 3Y-25.99%

More info and screens

0

5. Dividend

5.1 Amount

CJR-B does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CORUS ENTERTAINMENT INC-B SH

TSX:CJR-B (6/11/2025, 7:00:00 PM)

0.1

+0.01 (+5.26%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)04-11 2025-04-11/bmo
Earnings (Next)06-25 2025-06-25
Inst Owners4.14%
Inst Owner ChangeN/A
Ins Owners3.57%
Ins Owner ChangeN/A
Market Cap19.61M
Analysts43.08
Price Target0.09 (-10%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-21.25%
Min EPS beat(2)-75.76%
Max EPS beat(2)33.26%
EPS beat(4)2
Avg EPS beat(4)-55.69%
Min EPS beat(4)-251.7%
Max EPS beat(4)71.44%
EPS beat(8)5
Avg EPS beat(8)-5.39%
EPS beat(12)5
Avg EPS beat(12)-171.05%
EPS beat(16)8
Avg EPS beat(16)-128.06%
Revenue beat(2)0
Avg Revenue beat(2)-3.31%
Min Revenue beat(2)-3.66%
Max Revenue beat(2)-2.96%
Revenue beat(4)0
Avg Revenue beat(4)-5.28%
Min Revenue beat(4)-7.81%
Max Revenue beat(4)-2.96%
Revenue beat(8)0
Avg Revenue beat(8)-4.35%
Revenue beat(12)1
Avg Revenue beat(12)-3.71%
Revenue beat(16)1
Avg Revenue beat(16)-3.28%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-140%
EPS NY rev (1m)0%
EPS NY rev (3m)-199.99%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.89%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.42%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.02
P/FCF 0.23
P/OCF 0.2
P/B N/A
P/tB N/A
EV/EBITDA 1.36
EPS(TTM)-0.19
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)0.43
FCFY432.69%
OCF(TTM)0.51
OCFY505.08%
SpS6.11
BVpS-2.18
TBVpS-7.81
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -47.42%
ROE N/A
ROCE 8.92%
ROIC 6.43%
ROICexc 6.95%
ROICexgc 277.86%
OM 9.12%
PM (TTM) N/A
GM 53.83%
FCFM 7.08%
ROA(3y)-24.86%
ROA(5y)-17.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.4%
ROIC(5y)7.93%
ROICexc(3y)8.88%
ROICexc(5y)8.26%
ROICexgc(3y)101.91%
ROICexgc(5y)97.84%
ROCE(3y)11.67%
ROCE(5y)11.02%
ROICexcg growth 3Y19.08%
ROICexcg growth 5Y5.54%
ROICexc growth 3Y19.25%
ROICexc growth 5Y13.77%
OM growth 3Y-17.74%
OM growth 5Y-11.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.57%
GM growth 5Y-2.57%
F-Score4
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 12.33
Debt/EBITDA 1.45
Cap/Depr 2.33%
Cap/Sales 1.18%
Interest Coverage 1.65
Cash Conversion 13.8%
Profit Quality N/A
Current Ratio 0.65
Quick Ratio 0.65
Altman-Z -1.48
F-Score4
WACC4.14%
ROIC/WACC1.55
Cap/Depr(3y)2.34%
Cap/Depr(5y)2.46%
Cap/Sales(3y)1.13%
Cap/Sales(5y)1.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-186.36%
EPS 3Y-61.41%
EPS 5Y-43.12%
EPS Q2Q%-600%
EPS Next Y-573.8%
EPS Next 2Y-156.92%
EPS Next 3Y-25.99%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.72%
Revenue growth 3Y-6.28%
Revenue growth 5Y-5.52%
Sales Q2Q%-9.74%
Revenue Next Year-11.4%
Revenue Next 2Y-8.68%
Revenue Next 3Y-5.42%
Revenue Next 5YN/A
EBIT growth 1Y-40.38%
EBIT growth 3Y-22.91%
EBIT growth 5Y-16.24%
EBIT Next Year0.25%
EBIT Next 3Y6.51%
EBIT Next 5YN/A
FCF growth 1Y-31.59%
FCF growth 3Y-23.78%
FCF growth 5Y-18.48%
OCF growth 1Y-29.84%
OCF growth 3Y-21.92%
OCF growth 5Y-17.58%